525 related articles for article (PubMed ID: 27632223)
1. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.
Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S
Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223
[TBL] [Abstract][Full Text] [Related]
2. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies.
Gámez-Valero A; Prada-Dacasa P; Santos C; Adame-Castillo C; Campdelacreu J; Reñé R; Gascón-Bayarri J; Ispierto L; Álvarez R; Ariza A; Beyer K
Mov Disord; 2016 Jul; 31(7):1066-70. PubMed ID: 27027900
[TBL] [Abstract][Full Text] [Related]
3. High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.
Shiner T; Mirelman A; Gana Weisz M; Bar-Shira A; Ash E; Cialic R; Nevler N; Gurevich T; Bregman N; Orr-Urtreger A; Giladi N
JAMA Neurol; 2016 Dec; 73(12):1448-1453. PubMed ID: 27723861
[TBL] [Abstract][Full Text] [Related]
4. Features of
Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
[TBL] [Abstract][Full Text] [Related]
5. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
Alcalay RN; Caccappolo E; Mejia-Santana H; Tang M-; Rosado L; Orbe Reilly M; Ruiz D; Ross B; Verbitsky M; Kisselev S; Louis E; Comella C; Colcher A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Payami H; Molho E; Factor S; Ottman R; Clark LN; Marder K
Neurology; 2012 May; 78(18):1434-40. PubMed ID: 22442429
[TBL] [Abstract][Full Text] [Related]
6. The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews.
Shiner T; Mirelman A; Rosenblum Y; Kavé G; Weisz MG; Bar-Shira A; Goldstein O; Thaler A; Gurevich T; Orr-Urtreger A; Giladi N; Bregman N
J Alzheimers Dis; 2021; 80(3):1221-1229. PubMed ID: 33646158
[TBL] [Abstract][Full Text] [Related]
7. Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.
Creese B; Bell E; Johar I; Francis P; Ballard C; Aarsland D
Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):232-241. PubMed ID: 28548708
[TBL] [Abstract][Full Text] [Related]
8. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
[TBL] [Abstract][Full Text] [Related]
9. Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease.
Li Y; Sekine T; Funayama M; Li L; Yoshino H; Nishioka K; Tomiyama H; Hattori N
Neurobiol Aging; 2014 Apr; 35(4):935.e3-8. PubMed ID: 24126159
[TBL] [Abstract][Full Text] [Related]
10. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
[TBL] [Abstract][Full Text] [Related]
11. Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic
Usenko T; Bezrukova A; Basharova K; Panteleeva A; Nikolaev M; Kopytova A; Miliukhina I; Emelyanov A; Zakharova E; Pchelina S
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680941
[TBL] [Abstract][Full Text] [Related]
12. Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.
Lunde KA; Chung J; Dalen I; Pedersen KF; Linder J; Domellöf ME; Elgh E; Macleod AD; Tzoulis C; Larsen JP; Tysnes OB; Forsgren L; Counsell CE; Alves G; Maple-Grødem J
Alzheimers Dement; 2018 Oct; 14(10):1293-1301. PubMed ID: 29792872
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging, genetic, and enzymatic study in a Japanese family with a GBA gross deletion.
Ichinose Y; Ishiura H; Tanaka M; Yoshimura J; Doi K; Umeda T; Yamauchi H; Tsuchiya M; Koh K; Yamashiro N; Mitsui J; Goto J; Onishi H; Ohtsuka T; Shindo K; Morishita S; Tsuji S; Takiyama Y
Parkinsonism Relat Disord; 2019 Apr; 61():57-63. PubMed ID: 30528172
[TBL] [Abstract][Full Text] [Related]
14. [The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
Senkevich KA; Miliukhina IV; Beletskaia MV; Gracheva EV; Kudrevatykh AV; Nikolaev MA; Emelyanov AK; Kopytova AE; Timofeeva AA; Yakimovskii AF; Pchelina SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):81-86. PubMed ID: 29171494
[TBL] [Abstract][Full Text] [Related]
15. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
[TBL] [Abstract][Full Text] [Related]
17. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies.
Moors TE; Paciotti S; Ingrassia A; Quadri M; Breedveld G; Tasegian A; Chiasserini D; Eusebi P; Duran-Pacheco G; Kremer T; Calabresi P; Bonifati V; Parnetti L; Beccari T; van de Berg WDJ
Mol Neurobiol; 2019 Feb; 56(2):1344-1355. PubMed ID: 29948939
[TBL] [Abstract][Full Text] [Related]
19. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
Alcalay RN; Dinur T; Quinn T; Sakanaka K; Levy O; Waters C; Fahn S; Dorovski T; Chung WK; Pauciulo M; Nichols W; Rana HQ; Balwani M; Bier L; Elstein D; Zimran A
JAMA Neurol; 2014 Jun; 71(6):752-7. PubMed ID: 24756352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
